ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
SPSB1 Promotes Subcutaneous Adipose Hyperplasia in Facial Port-Wine Stains by Controlling HDAC1 Degradation and Stability Through Two Distinct Proteolytic Pathways.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Facial port-wine stains (PWS) are often complicated by subcutaneous adipose hyperplasia, yet the underlying cellular and molecular mechanisms remain unclear. Here, using single-cell RNA sequencing of facial adipose tissues, we identified a distinct subpopulation of adipose stem and progenitor cells that expressed high levels of SPSB1 in hypertrophic PWS. SPSB1 expression was transcriptionally upregulated by FOSL1. Functional assays revealed that SPSB1 potently promoted adipogenesis both in vitro and in vivo. Mechanistically, SPSB1, acting as an adapter for the Cullin-RING E3 ligase complex, directly interacted with HDAC1. It specifically mediated K48- and K29-linked polyubiquitination of HDAC1 at lysine residues 89 and 361, respectively, thereby targeting HDAC1 for degradation via both the ubiquitin-proteasome and autophagy-lysosome pathways. The degradation of HDAC1 increased chromatin accessibility of key adipogenic genes and promoted their expression. Furthermore, HDAC1 downregulation relieved its transcriptional repression on the SPSB1 promoter, establishing a positive feedback loop that perpetuated the pro-adipogenic signal. Collectively, our findings delineated a novel SPSB1-HDAC1 regulatory axis that drove pathological adipose hyperplasia in facial PWS, highlighting SPSB1 and HDAC1 as potential therapeutic targets for this condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.